Related Experiment Video
Updated: Mar 26, 2026
05:54
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
Published on: September 5, 2018
9.2K
Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture
Sarah-Louise Ryan1,2, Anne-Marie Baird1,2,3, Gisela Vaz4
11 Cancer and Ageing Research Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia .
Assay and Drug Development Technologies
|February 12, 2016
Summary
Three-dimensional (3D) cell cultures offer more realistic disease models than 2D cultures. However, many current 3D technologies are not compatible with automated high-throughput screening (HTS) for drug discovery.
Area of Science:
- Biotechnology
- Cell Biology
- Drug Discovery
Background:
- Traditional two-dimensional (2D) cell cultures have limitations in mimicking in vivo conditions.
- Three-dimensional (3D) multicellular structures are increasingly favored for in vitro disease modeling due to better in vivo representation.
Purpose of the Study:
- To review existing technologies for generating in vitro 3D disease models.
- To assess the compatibility of these 3D technologies with high-content screening (HCS) and high-throughput screening (HTS).
- To identify challenges hindering the integration of 3D cell systems into automated drug discovery workflows.
Main Methods:
- Literature review of various technologies for producing 3D in vitro disease models.
- Assessment of the amenability of these technologies to HCS and HTS.
- Discussion of practical challenges and potential solutions for deploying 3D cell systems in research.
Main Results:
- A significant number of current 3D cell culture technologies exhibit poor performance in automated drug discovery units.
- Incompatibility with HTS is a primary limitation for many existing 3D cell system technologies.
- Practical issues impede the widespread adoption of 3D cell systems in mainstream research.
Conclusions:
- There is a critical need for 3D cell culture technologies that are compatible with HTS for efficient drug discovery.
- Addressing the practical challenges is essential for the successful implementation of 3D cell systems in automated research platforms.
- Further development is required to bridge the gap between advanced 3D modeling and high-throughput screening capabilities.
